NCT00484497 (Cyclamax) is a NA clinical trial of cyclamax in Insomnia, sponsored by Persee Medica.

Who is sponsoring NCT00484497?

NCT00484497 is sponsored by Persee Medica.

What drugs are being tested in NCT00484497?

Interventions in NCT00484497: cyclamax.

Is NCT00484497 still recruiting?

NCT00484497 is currently completed. Last updated 8 June 2007.

Last reviewed 2007-06-08 · How we verify

NCT00484497: Cyclamax

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized, Double-Blind, Placebo-Controlled Trial for the Evaluation of a Food Supplement on Sleep Quality in Primary Insomnia Patient

Completed NA Last updated 8 June 2007

What this trial tests

NA trial testing cyclamax in Insomnia in 105 participants. Completed.

Timeline

1 September 2006

Quick facts

Lead sponsor	Persee Medica
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	105
Start date	1 September 2006
Sites	1 location across France

Drugs / interventions tested

cyclamax — full drug profile →

Conditions studied

Insomnia — all drugs for Insomnia →

Sponsor

Persee Medica — full company profile →

Who can join

Adults 25 to 65, any sex, with Insomnia. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sleep quality assessed by the Leed Sleep Evaluation Questionnaire, measured after one month of treatment

Sponsor's own description

The purpose of this study is to evaluate the efficacy on sleep quality of a food supplement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A dietary supplement to improve the quality of sleep: a randomized placebo controlled trial.
Cornu C, Remontet L, Noel-Baron F, Nicolas A, et al · · 2010 · cited 24× · PMID 20569455 · DOI 10.1186/1472-6882-10-29

Verify or expand the search:

Other recruiting trials for Insomnia

Currently open trials in the same condition.

NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting
NCT07071324 — CF Wellness Program · NA · recruiting
NCT07417813 — A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders · recruiting
NCT06348082 — Project Women's Insomnia Sleep Health Equity Study (WISHES) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00484497 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Persee Medica
Last refreshed: 8 June 2007

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00484497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing